BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9378965)

  • 41. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts.
    Henchoz S; Gauchat JF; Aubry JP; Graber P; Pochon S; Bonnefoy JY
    Immunology; 1994 Feb; 81(2):285-90. PubMed ID: 7512529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
    J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance.
    Rudich SM; Roux KH; Winchester RJ; Mongini PK
    J Exp Med; 1988 Jul; 168(1):247-66. PubMed ID: 2456368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade.
    Li X; Carter RH
    J Immunol; 1998 Dec; 161(11):5901-8. PubMed ID: 9834070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
    Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
    Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
    Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
    Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Function of CD23 in the response of human B cells to antigen.
    Reljić R; Cosentino G; Gould HJ
    Eur J Immunol; 1997 Feb; 27(2):572-5. PubMed ID: 9045933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CR2 ligands modulate human B cell activation.
    Bohnsack JF; Cooper NR
    J Immunol; 1988 Oct; 141(8):2569-76. PubMed ID: 2459218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis.
    Kozono Y; Duke RC; Schleicher MS; Holers VM
    Eur J Immunol; 1995 Apr; 25(4):1013-7. PubMed ID: 7737272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase.
    Barel M; Le Romancer M; Frade R
    J Immunol; 2001 Mar; 166(5):3167-73. PubMed ID: 11207269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human pre-B and B cell membrane mu-chains are noncovalently associated with a disulfide-linked complex containing a product of the B29 gene.
    Clark MR; Friedrich RJ; Campbell KS; Cambier JC
    J Immunol; 1992 Nov; 149(9):2857-63. PubMed ID: 1401917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells.
    Roberts T; Snow EC
    J Immunol; 1999 Apr; 162(8):4377-80. PubMed ID: 10201971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C3d plasma levels and CD21 expressing B-cells in children after ABO-incompatible heart transplantation: Alterations associated with blood group tolerance.
    Urschel S; Ryan LA; Larsen IM; Derkatz K; Rebeyka IM; Ross DB; West LJ
    J Heart Lung Transplant; 2014 Nov; 33(11):1149-56. PubMed ID: 24954883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus.
    Asokan R; Hua J; Young KA; Gould HJ; Hannan JP; Kraus DM; Szakonyi G; Grundy GJ; Chen XS; Crow MK; Holers VM
    J Immunol; 2006 Jul; 177(1):383-94. PubMed ID: 16785534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complement activation by cross-linked B cell-membrane IgM.
    Ohishi K; Kanoh M; Shinomiya H; Hitsumoto Y; Utsumi S
    J Immunol; 1995 Apr; 154(7):3173-9. PubMed ID: 7897206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD21(-/low) B cells in human blood are memory cells.
    Thorarinsdottir K; Camponeschi A; Cavallini N; Grimsholm O; Jacobsson L; Gjertsson I; Mårtensson IL
    Clin Exp Immunol; 2016 Aug; 185(2):252-62. PubMed ID: 27010233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct sequences in the cytoplasmic domain of complement receptor 2 are involved in antigen internalization and presentation.
    Barrault DV; Knight AM
    J Immunol; 2004 Mar; 172(6):3509-17. PubMed ID: 15004151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-ligation of ICAM-1 (CD54) and membrane IgM negatively affects B cell receptor signaling.
    van Horssen M; Loman S; Rijkers GT; Boom SE; Bloem AC
    Eur J Immunol; 1995 Jan; 25(1):154-8. PubMed ID: 7843226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis.
    Del Nagro CJ; Kolla RV; Rickert RC
    J Immunol; 2005 Oct; 175(8):5379-89. PubMed ID: 16210644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgG antibodies in food allergy influence allergen-antibody complex formation and binding to B cells: a role for complement receptors.
    Meulenbroek LA; de Jong RJ; den Hartog Jager CF; Monsuur HN; Wouters D; Nauta AJ; Knippels LM; van Neerven RJ; Ruiter B; Leusen JH; Hack CE; Bruijnzeel-Koomen CA; Knulst AC; Garssen J; van Hoffen E
    J Immunol; 2013 Oct; 191(7):3526-33. PubMed ID: 23997216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.